BioHealth & Medical Analyst Calls (AZN, NVS, NVO, CRL, IVGN, APPY, TWTI)
BNP Paribas overseas has lowered ratings of AstraZeneca (NYSE: AZN) to Underperform from Neutral; and raised Novartis (NYSE: NVS) to Neutral from Underperform. Goldman Sachs has raised Novo Nordisk...
View ArticleAspen Bio rises on possible FDA speculation (APPY)
Aspen Biopharma (Naddaq – APPY) shares are up more than 20% in Thursday trading on more than twice their normal volume, as traders appear to be anticipating FDA approval for the company’s AppyScore...
View ArticleAspenBio Pharma (APPY) Hurt On Share Pricing
AspenBio Pharma (AAPY) announced an it has priced a public offering of 4,482,609 shares of its common stock at $1.70 per share. The approximately $7.2 million of net proceeds, after deducting the...
View Article
More Pages to Explore .....
